IP41-19: Simulating the Impact of Adjuvant Immunotherapy in the NIAGARA Trial Using Gated Counterfactual Survival Modeling
Saturday, May 16, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
147A
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!